Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy
Cells · 16.05.2024 · 13 (10) · 853
DOI: 10.3390/cells13100853 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 16.05.2024. Verfasst von Serena Rocchi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Unit and Romagna Metropolitan Transplant Network-Ravenna, University of Bologna, 40126 Bologna, Italy. Hauptthemen laut MEDLINE: Multiple Myeloma, Transplantation, Autologous, Immunotherapy. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIL Ravenna (Associazione Italiana Leucemie).
Abstract (Originalsprache)
Upfront high-dose therapy with melphalan (HDM) followed by autologous stem cell transplantation (ASCT) has established itself as a core treatment for newly diagnosed multiple myeloma (NDMM) patients in the past 30 years. Induction therapy, HDM-ASCT, and subsequent consolidation and maintenance therapy comprise the current fundamental framework for MM treatment. The introduction of anti-CD38 monoclonal antibodies such as daratumumab and isatuximab has changed the treatment paradigm for transplant-eligible NDMM patients in that quadruplets have become the new standard induction therapy. The treatment landscape of MM is undergoing a transformative shift with the introduction of potent new immunotherapies, such as chimeric antigen receptor (CAR)-T cells and bispecific antibodies (BsAbs), which are currently used in the relapsed/refractory setting (RRMM) and are already being tested in the NDMM. This review will focus on the incorporation of immunotherapy in the treatment scenario of NDMM patients eligible for ASCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology Unit and Romagna Metropolitan Transplant Network-Ravenna, University of Bologna, 40126 Bologna, Italy.
ORCID-Profile: Giovanni Marconi, Francesco Lanza
Förderung
- AIL Ravenna (Associazione Italiana Leucemie)
Zitieren
APA
Rocchi, S., Zannetti, B. A., Marconi, G., & Lanza, F. (2024). Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy. Cells, 13(10), 853. https://doi.org/10.3390/cells13100853
Vancouver
Rocchi S, Zannetti BA, Marconi G, Lanza F. Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy. Cells. 2024;13(10):853. doi:10.3390/cells13100853
BibTeX
@article{Rocchi2024,
author = {Rocchi, Serena and Zannetti, Beatrice Anna and Marconi, Giovanni and Lanza, Francesco},
title = {Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy},
journal = {Cells},
year = {2024},
volume = {13},
number = {10},
pages = {853},
doi = {10.3390/cells13100853}
}
EUVIMED